Balaxi Pharmaceuticals Investor Relations Material
Latest events
Q1 25/26
5 Aug, 2025
Q4 24/25
30 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Balaxi Pharmaceuticals Limited
Access all reports
Balaxi Pharmaceuticals Limited is a pharmaceutical company engaged in the manufacturing, marketing, and distribution of branded generic formulations. The company offers a wide range of dosage forms including tablets, capsules, syrups, and injectables across various therapeutic segments such as anti-infectives, gastroenterology, and pain management. The company is headquartered in Hyderabad, India, and its shares are listed on the BSE.
Key slides for Balaxi Pharmaceuticals Limited
Q1 25/26
Balaxi Pharmaceuticals Limited
Q1 25/26
Balaxi Pharmaceuticals Limited
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
BALAXI
Country
🇮🇳 India